Related references
Note: Only part of the references are listed.Intersection of Hippo/YAP and Wnt/-catenin signaling pathways
Wesley M. Konsavage et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2013)
Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway
Marvin Xuejun Xu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Differential WNT Activity in Colorectal Cancer Confers Limited Tumorigenic Potential and Is Regulated by MAPK Signaling
David Horst et al.
CANCER RESEARCH (2012)
Ras Stabilization Through Aberrant Activation of Wnt/β-Catenin Signaling Promotes Intestinal Tumorigenesis
Woo-Jeong Jeong et al.
SCIENCE SIGNALING (2012)
Suppression of hydroxyurea-induced centrosome amplification by NORE1A and down-regulation of NORE1A mRNA expression in non-small cell lung carcinoma
Kazuya Shinmura et al.
LUNG CANCER (2011)
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase
Chen-Ying Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers
Maher S. Saifo et al.
MOLECULAR CANCER (2010)
H-Ras is degraded by Wnt/β-catenin signaling via β-TrCP-mediated polyubiquitylation
Sung-Eun Kim et al.
JOURNAL OF CELL SCIENCE (2009)
The Hippo-YAP pathway: new connections between regulation of organ size and cancer
Bin Zhao et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
SCFβ-TRCP controls oncogenic transformation and neural differentiation through REST degradation
Thomas F. Westbrook et al.
NATURE (2008)
Control of chromosome stability by the β-TrCP-REST-Mad2 axis
Daniele Guardavaccaro et al.
NATURE (2008)
The RASSF1A tumor suppressor
Howard Donninger et al.
JOURNAL OF CELL SCIENCE (2007)
A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK Pathways
D. Kim et al.
ONCOGENE (2007)
A novel protein-processing domain in Gli2 and Gli3 differentially blocks complete protein degradation by the proteasome
Yong Pan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
RASSF1C, an isoform of the tumor suppressor RASSF1A, promotes the accumulation of β-catenin by interacting with βTrCP
Emilie Estrabaud et al.
CANCER RESEARCH (2007)
Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis
Joanne W. Jang et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Polo-like kinase-1 controls proteasome-dependent degradation of claspin during checkpoint recovery
Ivan Mamely et al.
CURRENT BIOLOGY (2006)
Destruction of claspin by SCFβTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress
Niels Mailand et al.
MOLECULAR CELL (2006)
SCFβTrCP-mediated degradation of claspin regulates recovery from the DNA replication checkpoint response
Angelo Peschiaroli et al.
MOLECULAR CELL (2006)
Dual degradation signals control Gli protein stability and tumor formation
EG Huntzicker et al.
GENES & DEVELOPMENT (2006)
β-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases
Y Kanemori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Norel inhibits tumor cell growth independent of Ras or the MST1/2 kinases
Y Aoyama et al.
ONCOGENE (2004)
The dark side of Ras: regulation of apoptosis
AD Cox et al.
ONCOGENE (2003)
Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage
L Busino et al.
NATURE (2003)
The t(1;3) breakpoint-spanning involved in clear cell renal cell genes LSAMP and NORE1 are carcinomas
JD Chen et al.
CANCER CELL (2003)
RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor
MD Vos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung
MD Vos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
NF-κB, chemokine gene transcription and tumour growth
A Richmond
NATURE REVIEWS IMMUNOLOGY (2002)
NF-κB in cancer:: From innocent bystander to major culprit
M Karin et al.
NATURE REVIEWS CANCER (2002)
The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1
S Ortiz-Vega et al.
ONCOGENE (2002)
Identification of a novel Ras-regulated proapoptotic pathway
A Khokhlatchev et al.
CURRENT BIOLOGY (2002)
ATF4 degradation relies on a phosphorylation-dependent interaction with the SCFβTrCP ubiquitin ligase
I Lassot et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex
BA Schulman et al.
NATURE (2000)
SCFβ-TrcP ubiquitin ligase-mediated processing of NF-κB p105 requires phosphorylation of its C-terminus by IκB kinase
A Orian et al.
EMBO JOURNAL (2000)
Share Paper
